De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents

AIM: Recent studies raise concerns for higher incidence of hepatocellular carcinoma (HCC) after direct-acting antiviral therapy for hepatitis C virus (HCV). METHODS: In this study, using analysis of liver imaging pre- and post-DAA treatment, we queried new occurrence or ‘de novo’ of HCC in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuftinec, Gabriela, Loehfelm, Thomas, Corwin, Michael, Durbin-Johnson, Blythe, Candido, MarieChristi, Hluhanich, Rebecca, Sarkar, Souvik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168046/
https://www.ncbi.nlm.nih.gov/pubmed/30302197
http://dx.doi.org/10.2217/hep-2018-0003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168046/
https://www.ncbi.nlm.nih.gov/pubmed/30302197
http://dx.doi.org/10.2217/hep-2018-0003

Ejemplares similares